Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1995 Dec;71(842):720–724. doi: 10.1136/pgmj.71.842.720

The investigation of a patient with unexpected venous thrombosis.

J T Wilde 1
PMCID: PMC2398272  PMID: 8552534

Abstract

Over recent years a number of hereditary and acquired defects of the circulation's natural anticoagulant mechanisms have been characterised and shown to predispose affected individuals to thrombosis. It is important to attempt to diagnose a thrombophilia state in patients with a thrombotic tendency in order to provide appropriate management, especially during at-risk situations, both for themselves and asymptomatic relatives identified through family studies. This review defines the patients who should be investigated for an underlying thrombophilia state and describes the hereditary and acquired disorders which should be screened for within an investigation profile. The recently identified factor V Leiden mutation which appears to be the most common hereditary cause of a thrombotic tendency is described in detail and descriptions of the more established thrombophilia states are included. Although the factor V Leiden mutation accounts for a significant proportion of cases fulfilling the criteria for thrombophilia screening, a predisposing cause for thrombosis remains unidentifiable in a large number of patients making it likely that over the years to come new thrombophilia states will continue to be identified.

Full text

PDF
720

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allaart C. F., Poort S. R., Rosendaal F. R., Reitsma P. H., Bertina R. M., Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet. 1993 Jan 16;341(8838):134–138. doi: 10.1016/0140-6736(93)90003-y. [DOI] [PubMed] [Google Scholar]
  2. Bertina R. M., Broekmans A. W., Krommenhoek-van Es C., van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemost. 1984 Feb 28;51(1):1–5. [PubMed] [Google Scholar]
  3. Bertina R. M., Broekmans A. W., van der Linden I. K., Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost. 1982 Aug 24;48(1):1–5. [PubMed] [Google Scholar]
  4. Bertina R. M., Koeleman B. P., Koster T., Rosendaal F. R., Dirven R. J., de Ronde H., van der Velden P. A., Reitsma P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 May 5;369(6475):64–67. doi: 10.1038/369064a0. [DOI] [PubMed] [Google Scholar]
  5. Creagh M. D., Greaves M. Lupus anticoagulant. Blood Rev. 1991 Sep;5(3):162–167. doi: 10.1016/0268-960x(91)90033-9. [DOI] [PubMed] [Google Scholar]
  6. Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004–1008. doi: 10.1073/pnas.90.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dahlbäck B., Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1396–1400. doi: 10.1073/pnas.91.4.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986 Sep 15;261(26):12022–12027. [PubMed] [Google Scholar]
  9. EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
  10. Engesser L., Broekmans A. W., Briët E., Brommer E. J., Bertina R. M. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987 May;106(5):677–682. doi: 10.7326/0003-4819-106-5-677. [DOI] [PubMed] [Google Scholar]
  11. Gastineau D. A., Kazmier F. J., Nichols W. L., Bowie E. J. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985 Jul;19(3):265–275. doi: 10.1002/ajh.2830190308. [DOI] [PubMed] [Google Scholar]
  12. Gladson C. L., Scharrer I., Hach V., Beck K. H., Griffin J. H. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988 Feb 25;59(1):18–22. [PubMed] [Google Scholar]
  13. Griffin J. H., Evatt B., Wideman C., Fernández J. A. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993 Oct 1;82(7):1989–1993. [PubMed] [Google Scholar]
  14. Griffin J. H., Evatt B., Zimmerman T. S., Kleiss A. J., Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981 Nov;68(5):1370–1373. doi: 10.1172/JCI110385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horellou M. H., Conard J., Bertina R. M., Samama M. Congenital protein C deficiency and thrombotic disease in nine French families. Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1285–1287. doi: 10.1136/bmj.289.6454.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Juhan-Vague I., Valadier J., Alessi M. C., Aillaud M. F., Ansaldi J., Philip-Joet C., Holvoet P., Serradimigni A., Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost. 1987 Feb 3;57(1):67–72. [PubMed] [Google Scholar]
  17. Koster T., Rosendaal F. R., de Ronde H., Briët E., Vandenbroucke J. P., Bertina R. M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993 Dec 18;342(8886-8887):1503–1506. doi: 10.1016/s0140-6736(05)80081-9. [DOI] [PubMed] [Google Scholar]
  18. Legnani C., Palareti G., Biagi R., Coccheri S. Activated protein C resistance in deep-vein thrombosis. Lancet. 1994 Feb 26;343(8896):541–542. doi: 10.1016/s0140-6736(94)91494-x. [DOI] [PubMed] [Google Scholar]
  19. Malm J., Laurell M., Nilsson I. M., Dahlbäck B. Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost. 1992 Jul 6;68(1):7–13. [PubMed] [Google Scholar]
  20. Mannucci P. M., Valsecchi C., Krachmalnicoff A., Faioni E. M., Tripodi A. Familial dysfunction of protein S. Thromb Haemost. 1989 Sep 29;62(2):763–766. [PubMed] [Google Scholar]
  21. Marlar R. A., Montgomery R. R., Broekmans A. W. Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thromb Haemost. 1989 Jun 30;61(3):529–531. [PubMed] [Google Scholar]
  22. Reitsma P. H., Poort S. R., Allaart C. F., Briët E., Bertina R. M. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects. Blood. 1991 Aug 15;78(4):890–894. [PubMed] [Google Scholar]
  23. Romeo G., Hassan H. J., Staempfli S., Roncuzzi L., Cianetti L., Leonardi A., Vicente V., Mannucci P. M., Bertina R., Peschle C. Hereditary thrombophilia: identification of nonsense and missense mutations in the protein C gene. Proc Natl Acad Sci U S A. 1987 May;84(9):2829–2832. doi: 10.1073/pnas.84.9.2829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schafer A. I. Hypercoagulable states: molecular genetics to clinical practice. Lancet. 1994 Dec 24;344(8939-8940):1739–1742. doi: 10.1016/s0140-6736(94)92888-6. [DOI] [PubMed] [Google Scholar]
  25. Svensson P. J., Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994 Feb 24;330(8):517–522. doi: 10.1056/NEJM199402243300801. [DOI] [PubMed] [Google Scholar]
  26. Thaler E., Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981 Jun;10(2):369–390. [PubMed] [Google Scholar]
  27. Voorberg J., Roelse J., Koopman R., Büller H., Berends F., ten Cate J. W., Mertens K., van Mourik J. A. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet. 1994 Jun 18;343(8912):1535–1536. doi: 10.1016/s0140-6736(94)92939-4. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES